Day: September 13, 2021

Vornado Announces Pricing of Public Offering of $300 Million 4.45% Series O Cumulative Redeemable Preferred Shares and Calls for Redemption All of its $300 Million 5.70% Series K Cumulative Redeemable Preferred Shares

Vornado Announces Pricing of Public Offering of $300 Million 4.45% Series O Cumulative Redeemable Preferred Shares and Calls for Redemption All of its $300 Million 5.70% Series K Cumulative Redeemable Preferred Shares

NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) — VORNADO REALTY TRUST (NYSE: VNO) today announced the pricing of a public offering of $300 million perpetual 4.45% Series O Cumulative Redeemable Preferred Shares, at a price of $25.00 per share, pursuant to an effective registration statement. The offering is expected to close September 22, 2021, subject to customary closing conditions. The Company may redeem the Series O Preferred Shares at a redemption price of $25.00 per share on and after September 22, 2026. BofA Securities, J.P. Morgan, Morgan Stanley, UBS Investment Bank and Wells Fargo Securities are acting as joint book-running managers. The Company will use the net proceeds for the redemption of its 5.70% Series K Cumulative Redeemable Preferred Shares pursuant to the terms thereof. The offering is being made under the Company’s...

Continue reading

Parkland Corporation Announces September 2021 Dividend

Parkland Corporation Announces September 2021 Dividend

CALGARY, Alberta, Sept. 13, 2021 (GLOBE NEWSWIRE) — Parkland Corporation (“Parkland”) (TSX:PKI) announces that a dividend of $0.1029 per share will be paid on October 15, 2021 to shareholders of record on September 22, 2021. The dividend will be an ‘eligible dividend’ for Canadian income tax purposes. The ex-dividend date is September 21, 2021. Enhanced Dividend Reinvestment PlanParkland’s enhanced Dividend Reinvestment Plan (“Enhanced DRIP”) allows shareholders to reinvest their cash dividends to purchase additional Parkland shares from treasury at a 5% per share discount to the average of the daily volume weighted average trading prices during the Pricing Period. For further details on the Enhanced DRIP and the Pricing Period, please visit www.parkland.ca/en/investors/dividends. Shareholders who...

Continue reading

Bitcoin Well Announces Closing of Strategic Ghostlab Inc. Acquisition, Expanding Software Development and Deployment Capabilities

Bitcoin Well Announces Closing of Strategic Ghostlab Inc. Acquisition, Expanding Software Development and Deployment Capabilities

EDMONTON, Alberta, Sept. 13, 2021 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (TSXV: BTCW) (“Bitcoin Well” or the “Company”), is pleased to confirm that it has closed the previously announced acquisition of Ghostlab Inc. (“Ghostlab”) (the “Acquisition”), a software company that designs and develops software to improve the functionality and accessibility of modern financial technology and services, including Bitcoin ATM machines. Total consideration for the Acquisition was based on an enterprise value of up to $3.2 million, satisfied through the issuance of 2,758,621 common shares of Ghostlab at a price of $0.29 per common share, the closing price on the 11th trading day of the issuer, the assumption of debt of $1.8 million and the provision of an earn-out, all as more particularly described in the Company’s August 11, 2021 press release....

Continue reading

Integra Resources Announces US$15 Million Bought Deal Financing

Integra Resources Announces US$15 Million Bought Deal Financing

VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) — Integra Resources Corp. (“Integra” or the “Company”) (TSX-V:ITR; NYSE American:ITRG) is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Raymond James Ltd. (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 5,900,000 common shares of the Company (the “Common Shares”) at a price of US$2.55 per Common Share (the “Issue Price”), for total gross proceeds of US$15,045,000 (the “Offering”). The Company will also grant to the Underwriters an over-allotment option (the “Over-Allotment Option”) to purchase up to 885,000 additional Common Shares at the Issue Price. The Over-Allotment Option will be exercisable in whole or in part at any time for a period ending 30 days following...

Continue reading

Sean Whelan Appointed to Board of Directors

Sean Whelan Appointed to Board of Directors

ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to fill the vacancy created by the resignation of Christopher Wolfenberg. Robert Cohen, Zomedica’s Chief Executive Officer, commented that: “We all are very pleased to be joined by an executive with Sean’s sterling background. His broad and deep experience and expertise in financial matters, as well as his previous service with publicly listed companies, will be an excellent addition to our Board. I look forward to Sean assuming the Chairmanship of our Audit Committee, and to working with him on a wide variety of issues as Zomedica progresses. I also...

Continue reading

Jamf Holding Corp. Announces Proposed Private Placement of $325.0 Million of Convertible Senior Notes

Jamf Holding Corp. Announces Proposed Private Placement of $325.0 Million of Convertible Senior Notes

MINNEAPOLIS, Sept. 13, 2021 (GLOBE NEWSWIRE) — Jamf Holding Corp. (“Jamf,” “we,” “us” or “our”) (NASDAQ: JAMF), the standard in Apple Enterprise Management, today announced that it intends to offer, subject to market conditions and other factors, $325.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Jamf also intends to grant the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $48.75 million aggregate principal amount of notes. The notes will be senior unsecured obligations of Jamf and will accrue interest...

Continue reading

Immunocore Announces Upcoming Presentations at the European Society for Medical Oncology (ESMO) Congress 2021

Immunocore Announces Upcoming Presentations at the European Society for Medical Oncology (ESMO) Congress 2021

PRESS RELEASE Immunocore Announces Upcoming Presentations at the European Society for Medical Oncology (ESMO) Congress 2021 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US 13 September 2021) Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announces that new data and analysis from the Company’s lead program, tebentafusp, and its proprietary soluble TCR bispecific ImmTAC® platform will be presented at the European Society for Medical Oncology (ESMO) Congress, which will be held virtually from September 16-21, 2021. ORAL PRESENTATIONTitle: Early reduction in ctDNA, regardless of best RECIST...

Continue reading

Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

PRINCETON, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it closed its public offering of 23,000,000 shares of common stock at $31.00 per share. The closing includes 3,000,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares of common stock. Certara sold 4,500,000 shares of its common stock, and certain selling stockholders sold 18,500,000 shares of common stock in the offering. The gross proceeds to Certara from the offering were approximately $139.5 million, before deducting the underwriting discount and offering expenses. Certara intends to use the net proceeds from shares it is selling in the offering for general corporate purposes, including acquisitions. Certara did not receive any proceeds from the sale...

Continue reading

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference

Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conference on Tuesday, September 28, 2021, with a virtual presentation at 4:00 pm CET/10:00 am ET. A live webcast and replay of this event will be available on the Company’s investors relations website at https://investors.nyxoah.com/ About NyxoahNyxoah is a medical technology company focused on the development and commercialization of innovative solutions...

Continue reading

TREES Announces Closing of Series A Convertible Preferred Equity Offering; Convertible at $1.00 Per Share

TREES Announces Closing of Series A Convertible Preferred Equity Offering; Convertible at $1.00 Per Share

DENVER, Sept. 13, 2021 (GLOBE NEWSWIRE) — General Cannabis Corp. d/b/a TREES (OTCQB: CANN) (“TREES” or “the Company”), a vertically integrated licensed cannabis operator, is pleased to announce that it has completed the sale of 1,180 Units of Series A Convertible Preferred Equity. Each Unit consists of one share of Series A Convertible Preferred Stock (convertible into 1,000 shares of the Company’s Common Stock) and 300 warrants. The conversion price of the Common Stock at the time of conversion is $1.00 per share, a meaningful premium to the current market price of the Common Stock. The total gross proceeds of the offering was $1,180,000. The Company intends to use the proceeds for additional working capital and general corporate purposes. Furthermore, this infusion of capital strengthens the TREES balance sheet and helps to accelerate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.